Financhill
Buy
66

SGHT Quote, Financials, Valuation and Earnings

Last price:
$7.19
Seasonality move :
-6.3%
Day range:
$7.05 - $7.53
52-week range:
$2.03 - $9.24
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
4.87x
P/B ratio:
5.90x
Volume:
187.2K
Avg. volume:
260.4K
1-year change:
116.27%
Market cap:
$379.6M
Revenue:
$79.9M
EPS (TTM):
-$0.90

Analysts' Opinion

  • Consensus Rating
    Sight Sciences, Inc. has received a consensus rating of Hold. The company's average rating is a Hold based on 3 Buy ratings, 4 Hold ratings, and 0 Sell ratings.
  • Price Target Upside
    According to analysts' consensus price target of $8.68, Sight Sciences, Inc. has an estimated upside of 20.94% from its current price of $7.18.
  • Price Target Downside
    According to analysts, the lowest downside price target is $5.00 representing 100% downside risk from its current price of $7.18.

Fair Value

  • According to the consensus of 7 analysts, Sight Sciences, Inc. has 20.94% upside to fair value with a price target of $8.68 per share.

SGHT vs. S&P 500

  • Over the past 5 trading days, Sight Sciences, Inc. has underperformed the S&P 500 by -5.5% suggesting its relative strength compared to the major market average is weak at this time.

Share Buyback

  • Sight Sciences, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Sight Sciences, Inc. revenues have been falling on a year-over-year basis for 3 quarters in a row. In the most recent quarter Sight Sciences, Inc. reported revenues of $19.9M.

Earnings Growth

  • Sight Sciences, Inc. has grown year-over-year earnings for 3 quarters straight. In the most recent quarter Sight Sciences, Inc. reported earnings per share of -$0.16.
Enterprise value:
327.9M
EV / Invested capital:
--
Price / LTM sales:
4.87x
EV / EBIT:
--
EV / Revenue:
4.31x
PEG ratio (5yr expected):
--
EV / Free cash flow:
-10.38x
Price / Operating cash flow:
--
Enterprise value / EBITDA:
--
Gross Profit (TTM):
$65.4M
Return On Assets:
-35.23%
Net Income Margin (TTM):
-60.63%
Return On Equity:
-58.45%
Return On Invested Capital:
-38.96%
Operating Margin:
-39.71%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Income Statement
Revenue $82.8M $79.5M $76.1M $20.2M $19.9M
Gross Profit $70.1M $67.7M $65.4M $16.9M $17.2M
Operating Income -$63.2M -$49.7M -$45.4M -$11.2M -$7.9M
EBITDA -$62M -$49.1M -$44.8M -$11.1M -$7.8M
Diluted EPS -$1.28 -$1.01 -$0.90 -$0.22 -$0.16
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Balance Sheet
Current Assets $287.8M $222.3M $173.6M $140.5M $113.6M
Total Assets $291.1M $225.2M $176.6M $143.6M $116.3M
Current Liabilities $10.3M $17.4M $14.3M $13.8M $11.8M
Total Liabilities $45.1M $52.3M $49.6M $48.6M $52M
Total Equity $246M $172.9M $127.1M $95M $64.3M
Total Debt $33.7M $33.8M $33.8M $34.8M $40.1M
Trailing 12 Months Fiscal Quarters
Period Ending 2023-09-30 2024-09-30 2025-09-30 2024-09-30 2025-09-30
Cash Flow Statement
Cash Flow Operations -$56.2M -$25.6M -$31.1M $362K -$8.7M
Cash From Investing -$656K -$512K -$517K -$51K -$170K
Cash From Financing $1.5M $189K $5.7M $76K $25K
Free Cash Flow -$56.9M -$26.1M -$31.6M $311K -$8.9M
SGHT
Sector
Market Cap
$379.6M
$28.1M
Price % of 52-Week High
77.74%
51.87%
Dividend Yield
0%
0%
Shareholder Yield
-1.17%
-1.59%
1-Year Price Total Return
116.27%
-17.31%
Beta (5-Year)
--
0.495
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Sell
Level $7.74
200-day SMA
Buy
Level $4.52
Bollinger Bands (100)
Buy
Level 3.61 - 7.65
Chaikin Money Flow
Buy
Level 1.3M
20-day SMA
Sell
Level $8.15
Relative Strength Index (RSI14)
Sell
Level 39.66
ADX Line
Sell
Level 32.81
Williams %R
Buy
Level -94.0579
50-day SMA
Sell
Level $7.41
MACD (12, 26)
Sell
Level -0.02
25-day Aroon Oscillator
Sell
Level -36
On Balance Volume
Sell
Level -622.6K

Financial Scores

Sell
Altman Z-Score (Annual)
Level (-0.947)
Sell
CA Score (Annual)
Level (-0.9487)
Buy
Beneish M-Score (Annual)
Level (-3.8498)
Buy
Momentum Score
Level (10)
Sell
Ohlson Score
Level (2.0411)
Buy
Piotroski F Score (Annual)
Level (4)
Buy
Quality Ratio Score
Level (9)
Buy
Fundamental Score
Level (5)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Sight Sciences, Inc. is an ophthalmic medical device company, which focuses on the development and commercialization of surgical and nonsurgical technologies for the treatment of prevalent eye diseases. It operates through the Surgical Glaucoma and Dry Eye segments. The Surgical Glaucoma segment includes OMNI Surgical System for use in minimally invasive glaucoma procedures. The Dry Eye segment offers TearCare System and related components. The company was founded by Paul Badawi and David Y. Badawi in 2011 and is headquartered in Menlo Park, CA.

Stock Forecast FAQ

In the current month, SGHT has received 3 Buy ratings 4 Hold ratings, and 0 Sell ratings. The SGHT average analyst price target in the past 3 months is $8.68.

  • Where Will Sight Sciences, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Sight Sciences, Inc. share price will rise to $8.68 per share over the next 12 months.

  • What Do Analysts Say About Sight Sciences, Inc.?

    Analysts are divided on their view about Sight Sciences, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Sight Sciences, Inc. is a Sell and believe this share price will drop from its current level to $5.00.

  • What Is Sight Sciences, Inc.'s Price Target?

    The price target for Sight Sciences, Inc. over the next 1-year time period is forecast to be $8.68 according to 7 Wall Street analysts, 3 of them rate the stock a Buy, 0 rate the stock a Sell, and 4 analysts rate the stock a Hold.

  • Is SGHT A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Sight Sciences, Inc. is a Hold. 4 of 7 analysts rate the stock a Hold at this time.

  • How Can I Buy Shares Of SGHT?

    You can purchase shares of Sight Sciences, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Sight Sciences, Inc. shares.

  • What Is The Sight Sciences, Inc. Share Price Today?

    Sight Sciences, Inc. was last trading at $7.19 per share. This represents the most recent stock quote for Sight Sciences, Inc.. Yesterday, Sight Sciences, Inc. closed at $7.18 per share.

  • How To Buy Sight Sciences, Inc. Stock Online?

    In order to purchase Sight Sciences, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Why Is Amkor Stock Up So Much?
Why Is Amkor Stock Up So Much?

Semiconductor packaging and testing major Amkor (NASDAQ:AMKR) has started 2026…

Is Shopify Stock a Good Buy Now?
Is Shopify Stock a Good Buy Now?

eCommerce technology platform Shopify (NASDAQ:SHOP) delivered impressive returns in 2025…

Will The Magnificent 7 Stocks Go Up This Year?
Will The Magnificent 7 Stocks Go Up This Year?

2025 was another banner year for the Magnificent Seven stocks,…

Stock Ideas

Buy
52
Is NVDA Stock a Buy?

Market Cap: $4.5T
P/E Ratio: 63x

Buy
65
Is GOOG Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Buy
51
Is GOOGL Stock a Buy?

Market Cap: $4T
P/E Ratio: 41x

Alerts

Buy
100
ATGL alert for Jan 10

Alpha Technology Group Ltd. [ATGL] is up 47.05% over the past day.

Buy
71
NAIL alert for Jan 10

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 18.52% over the past day.

Buy
54
LGIH alert for Jan 10

LGI Homes, Inc. [LGIH] is up 13.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock